Opsens Inc T.OPS

If I understand well...

[Nadia6519]

... The increased loss is primarily due to higher operating expenses to drive growth in coronary products and preparation of the large-scale launch of SavvyWire for TAVR (Transcatheter Aortic Valve Replacement). 

Well, well,quite a scandal : spending money to drive growth!  What were they thinking?

I will never understand why some people expect companies to grow without spending. Or maybe they don't understand..

Anyways, conference calls usually provide answers and , most importantly, context.  Our conference call is in less than one hour.

GLTA

[retiredcf]

Good to see a voice of reason. We may close the day in the green depending on how well the conference call goes. GLTA

[Possibleidiot01]

Follow where the money went . Operating expenses for FY 2022 were $28.8 million compared with $19.6 million for FY 2021. The increase in operating expenses is primarily due to increased headcount in sales and marketing, research and development, and administration in preparation for the Company's launch of the SavvyWire for which the Company received regulatory clearance in Canada and